Clinical trials
Active, not recruiting Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
204 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 10 |
| 2018 | 9 |
| 2019 | 13 |
| 2020 | 11 |
| 2021 | 24 |
| 2022 | 25 |
| 2023 | 27 |
| 2024 | 32 |
| 2025 | 29 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 204 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 5 |
| Vanderbilt University Medical Center | 5 |
| University of Pennsylvania | 4 |
| Centre for Addiction and Mental Health | 3 |
| Dartmouth-Hitchcock Medical Center | 3 |
| Eli Lilly and Company | 3 |
| Instituto Mexicano del Seguro Social | 3 |
| University of Alabama at Birmingham | 3 |
| University of California, Los Angeles | 3 |
| University of California, San Diego | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 204 |
| Alzheimer Disease | 53 |
| Dementia | 40 |
| Memory Disorders | 11 |
| Stroke | 10 |
| Neurocognitive Disorders | 8 |
| Inflammation | 7 |
| Parkinson Disease | 7 |
| Mental Disorders | 6 |
| Anxiety Disorders | 5 |
Trials
Showing 1 to 25 of 204. Each trial links to its page on Pharma Observatory.
104 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.